Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITA
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Major histocompatibility complex (MHC) class II genes are expressed constitutively in only a few cell types, but they can be induced in the majority of them, in particular by interferon-gamma (IFN-gamma). The MHC class II transactivator gene CIITA is defective in a form of primary MHC class II deficiency. Here it is shown that CIITA expression is controlled and induced by IFN-gamma. A functional CIITA gene is necessary for class II induction, and transfection of CIITA is sufficient to activate expression of MHC class II genes in class II-negative cells in the absence of IFN-gamma. CIITA is therefore a general regulator of both inducible and constitutive MHC class II expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The expression of PD-L1 and MHC II, which may cause exhaustion by binding to T-cell programmed cell death protein 1 (PD-1) and lymphocyte activation gene 3 (LAG-3), respectively, is regulated by tumor interferon (IFN) signaling.”
From Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma (2021) · cites this paper as [27]
Citations
Cites
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
Schindler, C., Shuai, K., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1496401 · Cited by 899
Steimle, V (1993) · Cell · doi:10.1016/0092-8674(93)90685-j · Cited by 864
A Single Phosphotyrosine Residue of Stat91 Required for Gene Activation by Interferon-γ
Shuai, K., Stark, G. R., Kerr, L. M., & Darnell, J. E. (1993) · Science · doi:10.1126/science.7690989 · Cited by 802
Activation of Transcription by IFN-γ: Tyrosine Phosphorylation of a 91-kD DNA Binding Protein
Shuai, K., Schindler, C., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1281555 · Cited by 775
Collins, T., Korman, A. J., Wake, C. T., Boss, J. M., Kappes, D. J., Fiers, W., Ault, K. A., Gimbrone, M. A., Strominger, J. L., & Pober, J. S. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.15.4917 · Cited by 585
Sequences And Factors: A Guide To Mhc Class-Ii Transcription
Glimcher, L. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.13 · Cited by 534
Benoist, C., & Mathis, D. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003341 · Cited by 457
Müller, M., Laxton, C., Briscoe, J., Schindler, C., Improta, T., Darnell, J. E., Stark, G. R., & Kerr, I. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06106.x · Cited by 411
Detection of a novel human class II HLA antigen
Watson, A. J., DeMars, R., Trowbridge, I. S., & Bach, F. H. (1983) · Nature · doi:10.1038/304358a0 · Cited by 376
Cited by
Items 101–200 of 899
NLRC5 Cooperates with the RFX Transcription Factor Complex To Induce MHC Class I Gene Expression
Meissner, T. B., Liu, Y.-J., Lee, K.-H., Li, A., Biswas, A., van Eggermond, M. C. J. A., van den Elsen, P. J., & Kobayashi, K. S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103160 · Cited by 131
Morris, A. C., Beresford, G. W., Mooney, M. R., & Boss, J. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4781-4791.2002 · Cited by 129
“CIITA expression can be induced by IFN- in a time frame that precedes that of MHC class II genes (6, 40).”
BackgroundRuan, R., Li, L., Li, X., Huang, C., Zhanmin, Z., Zhong, H., Zeng, S., Shi, Q., Yang, X., Zeng, Q., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01761-7 · Cited by 144
“Early experiments have shown that IFN-γ plays a role in inducing the expression of MHC Class II molecules [75, 76].”
Wang, Y., Curry, H. M., Zwilling, B. S., & Lafuse, W. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5687 · Cited by 146
The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32
Fontes, J. D., Jiang, B., & Peterlin, B. M. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.12.2522 · Cited by 126
Stickel, N., Hanke, K., Marschner, D., Prinz, G., Köhler, M., Melchinger, W., Pfeifer, D., Schmitt-Graeff, A. H., Brummer, T., Heine, A., et al. (2017) · Leukemia · doi:10.1038/leu.2017.137 · Cited by 128
Single-Cell Profiling of Ebola Virus Disease In Vivo Reveals Viral and Host Dynamics
Kotliar, D., Lin, A. E., Logue, J., Hughes, T. K., Khoury, N. M., Raju, S. S., Wadsworth, M. H., Chen, H. M., Kurtz, J. R., Dighero-Kemp, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.002 · Cited by 127
Li, W., Kim, M.-G., Gourley, T. S., McCarthy, B. P., Sant’Angelo, D. B., & Chang, C. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.002 · Cited by 130
Regulation of hepatocyte fate by interferon-γ
Horras, C. J., Lamb, C. L., & Mitchell, K. A. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.01.001 · Cited by 119
“Along these lines, IFN-γ has been shown to induce MHC class I and class II proteins through mechanisms that involve IRF-1 and CIITA, respectively [115,116], and enhance antigen processing by modulating expression of enzymatic subunits of the proteosome [117].”
BackgroundAkasaka, H., Akasaka, T., Kurata, M., Ueda, C., Shimizu, A., Uchiyama, T., & Ohno, H. (2000) · PubMed · Cited by 120
Cloning and functional characterization of mammalian homologues of the COPII component Sec23.
Paccaud, J. P., Reith, W., Carpentier, J. L., Ravazzola, M., Amherdt, M., Schekman, R., & Orci, L. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.10.1535 · Cited by 120
Haskó, G., Szabó, C., Németh, Z. H., Salzman, A. L., & Vizi, E. S. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199802)28:02<468::aid-immu468>3.0.co;2-z · Cited by 62
Characterization of lung inflammation and its impact on macrophage function in aging
Canan, C. H., Gokhale, N. S., Carruthers, B., Lafuse, W. P., Schlesinger, L. S., Torrelles, J. B., & Turner, J. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.4a0214-093rr · Cited by 117
Interferon‐γ‐induced chromatin remodeling at the CIITA locus is BRG1 dependent
Pattenden, S. G., Klose, R. J., Karaskov, E., & Bremner, R. (2002) · The EMBO Journal · doi:10.1093/emboj/21.8.1978 · Cited by 141
Primary immunodeficiency diseases: an experimental model for molecular medicine
Fischer, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04959-x · Cited by 128
CIITA and Its Dual Roles in MHC Gene Transcription
Devaiah, B. N., & Singer, D. S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00476 · Cited by 127
“However, γ-interferon exposure induces de novo CIITA expression in most cell types (12, 13).”
BackgroundTNF-α Induces Macroautophagy and Regulates MHC Class II Expression in Human Skeletal Muscle Cells
Keller, C. W., Fokken, C., Turville, S. G., Lünemann, A., Schmidt, J., Münz, C., & Lünemann, J. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.159392 · Cited by 115
NLRC5 Controls Basal MHC Class I Gene Expression in an MHC Enhanceosome-Dependent Manner
Neerincx, A., Rodriguez, G. M., Steimle, V., & Kufer, T. A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103136 · Cited by 121
Luo, Y., Xia, Y., Liu, D., Li, X., Li, H., Liu, J., Zhou, D., Dong, Y. J., Li, X., Qian, Y., et al. (2024) · Cell · doi:10.1016/j.cell.2024.06.013 · Cited by 131
“85,86 A long latency period as such allows HGSOC tumors with genomic instability to produce IFN persistently.”
BackgroundYang, W., Vethanayagam, R. R., Dong, Y., Cai, Q., & Hu, B. H. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.081 · Cited by 115
“Second, we observed an increase in the expression level of CIITA, a non-DNA binding transactivator that functions as a molecular switch controlling both constitutive and inducible MHC-II expression (Chang et al., 1994; Steimle et al., 1994).”
ICSBP/IRF-8 retrovirus transduction rescues dendritic cell development in vitro
Tsujimura, H., Tamura, T., Gongora, C., Aliberti, J., Reis e Sousa, C., Sher, A., & Ozato, K. (2003) · Blood · doi:10.1182/blood-2002-05-1327 · Cited by 114
“class II specific transactivator CIITA, whose expression is differentially regulated by cell type specific promoters.(32) It has been shown that promoter I is selectively utilized in DCs.”
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
Li, Y.-R., Zhou, Y., Kim, K. G., Zhu, Y., Ma, F., Yu, J., Wang, Y.-C., Chen, X., Li, Z., Zeng, S., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100449 · Cited by 146
“70 Ablation of B2M and CIITA genes can be achieved by using the powerful gene-ed-itingtoolsliketheCRISPR-Cas9/guideRNA(gRNA)system.”
BackgroundStatins as Immunomodulatory Agents
Mach, F. (2004) · Circulation · doi:10.1161/01.cir.0000129502.10459.fe · Cited by 111
Lu, H., Riley, J. L., Babcock, G. T., Huston, M. M., Stark, G. R., Boss, J. M., & Ransohoff, R. M. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.5.1517 · Cited by 106
“II transcription in the absence of IFN-~/ (30, 31, 33).”
BackgroundAccolla, R. S., Ramia, E., Tedeschi, A., & Forlani, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01806 · Cited by 120
“In depth analysis of the molecular mechanism responsible of this finding demonstrated that the CIITA promoter IV, the specific promoter activated by the IFNγ (60), was silenced by hypermethylation of its sequence and thus rendered developmentally unresponsive in liver cells (59).”
BackgroundInfluentialInduction of the rainbow trout MHC class I pathway during acute IHNV infection
Hansen, J. D., & Patra, S. L. (2002) · Immunogenetics · doi:10.1007/s00251-002-0509-x · Cited by 111
New Evidence for Beneficial Effects of Statins Unrelated to Lipid Lowering
Palinsk, W. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.1.3 · Cited by 109
Hake, S. B., Masternak, K., Kammerbauer, C., Janzen, C. J., Reith, W., & Steimle, V. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7716-7725.2000 · Cited by 108
“CIITA is the obligatory mediator of IFN-g-induced MHC-II expression (7, 9, 47).”
BackgroundRaval, A., Howcroft, T. K., Weissman, J. D., Kirshner, S., Zhu, X.-S., Yokoyama, K. K., Ting, J. P. ‐., & Singer, D. S. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00159-9 · Cited by 120
“CIITA is constitutively ex-Tsukuba pressed in B lymphocytes and other professionalJapan antigen presenting cells, but can be induced in other cell types in response to g-IFN (Chin et al., 1994; Steimle et al., 1994).”
BackgroundAlternate interferon signaling pathways
Kalvakolanu, D. V. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00070-6 · Cited by 120
Regulation of Class II MHC Expression in APCs: Roles of Types I, III, and IV Class II Transactivator
Pai, R. K., Askew, D., Boom, W. H., & Harding, C. V. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1326 · Cited by 107
Frohman, E. M., Filippi, M., Stuve, O., Waxman, S. G., Corboy, J., Phillips, J. T., Lucchinetti, C., Wilken, J., Karandikar, N., Hemmer, B., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.9.1345 · Cited by 106
“41 The clinical significance of this cytokine in MS pathogenesis was demonstrated when it was shown that the systemic administration of interferon (cid:1) caused exacerbations in patients with relapsing-remitting MS. 42 Numerous approved and experimental MS pharmaco-therapies have been shown to…”
BackgroundVeillard, N. R., & Mach, F. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/pl00012505 · Cited by 127
NOD‐like receptor (NLR) signaling beyond the inflammasome
Shaw, P. J., Lamkanfi, M., & Kanneganti, T. (2010) · European Journal of Immunology · doi:10.1002/eji.200940211 · Cited by 106
Post-infectious group A streptococcal autoimmune syndromes and the heart
Martin, W. J., Steer, A. C., Smeesters, P. R., Keeble, J., Inouye, M., Carapetis, J. R., & Wicks, I. P. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.04.005 · Cited by 112
“high levels of IFNγ, which is produced in RHD heart valves [252-254].”
BackgroundO’Keefe, G. M., Nguyen, V. T., Ping Tang, L., & Benveniste, E. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2260 · Cited by 103
Srivastava, M. K., Bosch, J. J., Thompson, J. A., Ksander, B. R., Edelman, M. J., & Ostrand‐Rosenberg, S. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0490-9 · Cited by 112
“MHC II and Ii are transcriptionally coordinately regulated by the MHC class II transactivator, CIITA [ 40 ].”
BackgroundEidson, L. N., Kannarkat, G. T., Barnum, C. J., Chang, J., Chung, J., Caspell-Garcia, C., Taylor, P., Mollenhauer, B., Schlossmacher, M. G., Ereshefsky, L., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0935-1 · Cited by 102
“IFNγ regulates the expression of major histocompatibility complex II (MHCII) on monocytes, microglia, and macrophages [90].”
BackgroundNLRs, inflammasomes, and viral infection
Jacobs, S. R., & Damania, B. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0312132 · Cited by 117
Cui, J., Qin, L., Zhang, J., Abrahimi, P., Li, H., Li, G., Tietjen, G. T., Tellides, G., Pober, J. S., & Mark Saltzman, W. (2017) · Nature Communications · doi:10.1038/s41467-017-00297-x · Cited by 101
Liver Sinusoidal Endothelial Cells Are a Site of Murine Cytomegalovirus Latency and Reactivation
Seckert, C. K., Renzaho, A., Tervo, H.-M., Krause, C., Deegen, P., Kühnapfel, B., Reddehase, M. J., & Grzimek, N. K. A. (2009) · Journal of Virology · doi:10.1128/jvi.00870-09 · Cited by 100
“Since various MHC-II-negative cell types conditionally express MHC-II upon activation by cytokines, by gamma interferon in particular (106), we surmised that the MHC-II CD146 cells may not represent an independent cell population but rather LSECs in a state of activity, which might in part explain the different findin…”
ResultChin, K.-C., Li, G. G.-X., & Ting, J. P.-Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2501 · Cited by 101
Roy, S. K., Hu, J., Meng, Q., Xia, Y., Shapiro, P. S., Reddy, S. P., Platanias, L. C., Lindner, D. J., Johnson, P. F., Pritchard, C. A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122075799 · Cited by 118
GTP Binding by Class II Transactivator: Role in Nuclear Import
Harton, J. A., Cressman, D. E., Chin, K.-C., Der, C. J., & -Y. Ting, J. P. (1999) · Science · doi:10.1126/science.285.5432.1402 · Cited by 99
Regulation of human leukocyte antigen expression in human conjunctival epithelium.
Tsubota, K., Fukagawa, K., Fujihara, T., Shimmura, S., Saito, I., Saito, K., & Takeuchi, T. (1999) · PubMed · Cited by 99
O'Keefe, G. M., Nguyen, V. T., & Benveniste, E. N. (2002) · Journal of NeuroVirology · doi:10.1080/13550280290100941 · Cited by 116
“…of CIITA in IFN-κ –inducible cells results in the expression of class II MHC mRNA and protein in the absence of IFN-κ stimulation, illustrating that ectopic expression of CIITA is able to bypass the requirement of IFN-κ –induced signaling (Chin et al, 1994; Lee et al, 1997; Steimle et al, 1994).”
BackgroundA distant trophoblast-specific enhancer controls HLA-G expression at the maternal–fetal interface
Ferreira, L. M. R., Meissner, T. B., Mikkelsen, T. S., Mallard, W., O’Donnell, C. W., Tilburgs, T., Gomes, H. A. B., Camahort, R., Sherwood, R. I., Gifford, D. K., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602886113 · Cited by 110
“Upon interaction with a transcriptional activator—CIITA for class II and NLRC5 for class I genes—a multiprotein transcription factor complex is assembled, forming the MHC enhanceosome (17, 41, 42).”
BackgroundLaha, T. T., Hawley, M., Rock, K. L., & Goldberg, A. L. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00287-j · Cited by 97
Linhoff, M. W., Harton, J. A., Cressman, D. E., Martin, B. K., & Ting, J. P.-Y. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.3001-3011.2001 · Cited by 98
“The N terminus of CIITA contains the acidic domain (30-130), and the proline (P)-, serine (S)-, and threonine (T)-rich regions.”
BackgroundImmune-mediated control of Chlamydia infection
Roan, N. R., & Starnbach, M. N. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01069.x · Cited by 96
“In addition to its role in directly limiting Chlamydia replication, IFN-g also plays an important role in adaptive immunity as it can enhance the presentation of antigens to both CD4+ and CD8+ T cells (Gaczynska et al., 1993; Steimle et al., 1994).”
BackgroundCorrection of age-associated defects in dendritic cells enables CD4+ T cells to eradicate tumors
Zhivaki, D., Kennedy, S. N., Park, J., Borriello, F., Devant, P., Cao, A., Bahleda, K. M., Murphy, S. M., Aubin, C., Evavold, C. L., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.026 · Cited by 108
MHC Class II Presentation in Autoimmunity
Ishina, I. A., Zakharova, M. Y., Kurbatskaia, I. N., Mamedov, A. E., Belogurov, A. A., & Gabibov, A. G. (2023) · Cells · doi:10.3390/cells12020314 · Cited by 116
“High IFN-γ levels increase the number of MHC-II molecules on professional and nonprofessional APCs, thereby altering the composition of the MHC peptidome in the inflammatory area [105].”
BackgroundOdeberg, J., Plachter, B., Brandén, L. J., & Söderberg‐Nauclér, C. (2003) · Blood · doi:10.1182/blood-2002-05-1504 · Cited by 96
Giroux, M., Schmidt, M., & Descoteaux, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4187 · Cited by 95
“CIITA is a master regulator of both inducible and constitutive MHC-II expression (7, 9).”
BackgroundMethylation of Class II trans-Activator Promoter IV: A Novel Mechanism of MHC Class II Gene Control
Morris, A. C., Spangler, W. E., & Boss, J. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4143 · Cited by 95
Sendide, K., Deghmane, A.-E., Pechkovsky, D., Av-Gay, Y., Talal, A., & Hmama, Z. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5324 · Cited by 94
Associations and Interactions between Bare Lymphocyte Syndrome Factors
DeSandro, A. M., Nagarajan, U. M., & Boss, J. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.17.6587-6599.2000 · Cited by 94
Mice lacking the transcription factor CIITA--a second look.
Williams, G. S., Malin, M., Vremec, D., Chang, C. H., Boyd, R., Benoist, C., & Mathis, D. (1998) · International Immunology · doi:10.1093/intimm/10.12.1957 · Cited by 93
“Previous studies had suggested that the class I and class II pathways were linked together in the response to IFN-γ through IFN response factor (IRF)-1 (18), but there existed no evidence implicating CIITA in class I gene expression ( 13 ).”
BackgroundMelanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2
Luo, N., Formisano, L., Gonzalez-Ericsson, P. I., Sanchez, V., Dean, P. T., Opalenik, S. R., Sanders, M. E., Cook, R. S., Arteaga, C. L., Johnson, D. B., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1438106 · Cited by 87
Song, Z., Krishna, S., Thanos, D., Strominger, J. L., & Ono, S. J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1763 · Cited by 72
Lüder, C. G. K., Lang, C., Giraldo‐Velásquez, M., Algner, M., Gerdes, J., & Groß, U. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00320-x · Cited by 107
“The CIITA protein then acts itself as a trans-acting factor and is absolutely required to initiate gene transcription by cooperative binding to the MHC class II promoter (Steimle et al., 1994).”
BackgroundInterferon gamma in autoimmunity: A complicated player on a complex stage
Lees, J. R. (2014) · Cytokine · doi:10.1016/j.cyto.2014.10.014 · Cited by 96
“[73] Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.”
BackgroundInfluentialThe MHC Class II Transactivator CIITA: Not (Quite) the Odd-One-Out Anymore among NLR Proteins
Machado, J. A. L., & Steimle, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031074 · Cited by 99
“CIITA mRNA is induced by IFNγ, and ectopic expression of CIITA is necessary and sufficient to induce MHC-II gene expression [4,5].”
BackgroundKoivisto, P. A., & Rantala, I. S. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199901)187:2<191::aid-path206>3.0.co;2-3 · Cited by 49
IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
Dong, Y., Rohn, W. M., & Benveniste, E. N. (1999) · PubMed · Cited by 89
Antigen presentation safeguards the integrity of the hematopoietic stem cell pool
Hernández-Malmierca, P., Vonficht, D., Schnell, A., Uckelmann, H. J., Bollhagen, A., Mahmoud, M. A. A., Landua, S.-L., van der Salm, E., Trautmann, C. L., Raffel, S., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.04.007 · Cited by 86
Heise, M. T., Connick, M., & Virgin, H. W. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.1037 · Cited by 94
“To assess MCMV effects on expression of IRF-1 protein, we assayed nuclear extracts of Mfs that were mock or MCMV infected for a total of 5 h, with IFN-g treatment during the final 4 h for binding to the IRF-E element of the murine (29-59) oligoadenylate synthase promoter (35) by EMSA.”
MethodModulation of Gene Expression by the MHC Class II Transactivator
Nagarajan, U. M., Bushey, A., & Boss, J. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5078 · Cited by 87
“B y mediating both constitutive and IFNinducible expression, the class II transactivator (CIITA) 3 functions as a master regulator of MHC class II genes (1, 2).”
BackgroundVillard, J., Peretti, M., Masternak, K., Barras, E., Caretti, G., Mantovani, R., & Reith, W. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3364-3376.2000 · Cited by 86
“by on February 22, 2010 mcb.asm.org Downloaded from 1) (45, 46, 68, 69 ).”
Distinct interferon signatures stratify inflammatory and dysimmune myopathies
Rigolet, M., Hou, C., Amer, Y. B., Aouizerate, J., Periou, B., Gherardi, R. K., Lafuste, P., & Authier, F. (2019) · RMD Open · doi:10.1136/rmdopen-2018-000811 · Cited by 85
The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People
Lim, E. Y., Jackson, S. E., & Wills, M. R. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00202 · Cited by 93
Antiinflammatory and Immunomodulatory Properties of Statins
Shovman, O., Levy, Y. M., Gilburd, B., & Shoenfeld, Y. (2002) · Immunologic Research · doi:10.1385/ir:25:3:271 · Cited by 88
Zhang, Y., Zhang, Y.-Y., Ogata, M., Chen, P., Harada, A., Hashimoto, S.-I., & Matsushima, K. (1999) · Blood · doi:10.1182/blood.v93.4.1208 · Cited by 96
Ng, C. T., Fong, L. Y., & Abdullah, M. N. H. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156208 · Cited by 106
Gourley, T., Roys, S., Lukacs, N. W., Kunkel, S. L., Flavell, R. A., & Chang, C.-H. (1999) · Immunity · doi:10.1016/s1074-7613(00)80037-0 · Cited by 81
Early Alteration in Leukocyte Populations and Th1/Th2 Function in Ethanol-Consuming Mice
Starkenburg, S., Munroe, M. E., & Waltenbaugh, C. (2001) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200108000-00019 · Cited by 81
Isolation of a B-cell-specific promoter for the human class II transactivator
Lennon, A., Ottone, C., Rigaud, G., Deaven, L. L., Longmire, J., Fellous, M., Bono, R., & Alcaïde‐Loridan, C. (1997) · Immunogenetics · doi:10.1007/s002510050202 · Cited by 82
“However, in the last two cell types, its transcription can be induced after IFN-γ treatment (Steimle et al. 1993, 1994).”
BackgroundMethodInfluentialYasumizu, Y., Ohkura, N., Murata, H., Kinoshita, M., Funaki, S., Nojima, S., Kido, K., Kohara, M., Motooka, D., Okuzaki, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31951-8 · Cited by 92
NLRC5: a newly discovered MHC class I transactivator (CITA)
Meissner, T. B., Li, A., & Kobayashi, K. S. (2011) · Microbes and Infection · doi:10.1016/j.micinf.2011.12.007 · Cited by 81
“The induction of CIITA expression by IFN-γ precedes the upregulation of MHC class II [40](Fig.”
BackgroundDeSandro, A., Nagarajan, U., & Boss, J. (1999) · American Journal of Human Genetics · doi:10.1086/302519 · Cited by 87
“This complex is inactive in the absence of CIITA, a factor that is constitutively expressed in B lymphocytes and other antigen-presenting cells, and that is inducible by IFN-g in most other cell types (Steimle et al. 1994).”
BackgroundUnusual expression of human lymphocyte antigen class II in normal renal microvascular endothelium
Muczynski, K. A., Cotner, T., & Anderson, S. K. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002488.x · Cited by 80
Roy, E. L., Mühlethaler‐Mottet, A., Davrinche, C., Mach, B., & Davignon, J. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6582-6589.1999 · Cited by 94
Jak/STAT signaling is involved in the inflammatory infiltration of the kidneys in MRL/lpr mice
Wang, S., Yang, N., Zhang, L., Huang, B., Tan, H., Liang, Y., Li, Y., & Yu, X. (2010) · Lupus · doi:10.1177/0961203310367660 · Cited by 84
Immune-inflammatory mechanisms in IFNγ-mediated anti-tumor activity
Tannenbaum, C. S., & Hamilton, T. A. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0314 · Cited by 85
Iwama, A., Pan, J., Zhang, P., Reith, W., Mach, B., Tenen, D. G., & Sun, Z. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.3940 · Cited by 79
“However, it has been demonstrated that transactivation mediated by RFX5 fully relies on a coactivator, CIITA, the expression of which is restricted to dendritic and B cells and is inducible by gamma interferon in a variety of other cell types (17, 18, 35, 36 ).”
BackgroundNickerson, K., Sisk, T. J., Inohara, N., Yee, C. S. K., Kennell, J., Cho, M.-C., Yannie, P. J., Núñez, G., & Chang, C.-H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101295200 · Cited by 78
Efficient Gene Disruption in Cultured Primary Human Endothelial Cells by CRISPR/Cas9
Abrahimi, P., Chang, W. G., Kluger, M. S., Qyang, Y., Tellides, G., Saltzman, W. M., & Pober, J. S. (2015) · Circulation Research · doi:10.1161/circresaha.117.306290 · Cited by 86
Yoon, H. S., Scharer, C. D., Majumder, P., Davis, C. W., Butler, R., Zinzow-Kramer, W. M., Skountzou, I., Koutsonanos, D. G., Ahmed, R., & Boss, J. M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103371 · Cited by 77
Jackson, S. E., Sedikides, G. X., Mason, G. M., Okecha, G., & Wills, M. R. (2017) · Journal of Virology · doi:10.1128/jvi.02128-16 · Cited by 83
“these cells both constitutively express MHC class II (55) and are permissive for lytic CMV”
BackgroundDong, Y., Tang, L., Letterio, J. J., & Benveniste, E. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.311 · Cited by 77
CHON, S. Y., HASSANAIN, H. H., PINE, R., & GUPTA, S. L. (1995) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1995.15.517 · Cited by 77
Blocking MHC class II on human endothelium mitigates acute rejection
Abrahimi, P., Qin, L., Chang, W. G., Bothwell, A. L. M., Tellides, G., Saltzman, W. M., & Pober, J. S. (2016) · JCI Insight · doi:10.1172/jci.insight.85293 · Cited by 76
Rajamäki, K., Mäyränpää, M. I., Risco, A., Tuimala, J., Nurmi, K., Cuenda, A., Eklund, K. K., Öörni, K., & Kovanen, P. T. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.307312 · Cited by 75
“Activators of the NLRP3 Inflammasome Downregulate CIITA and Class II HLA Expression CIITA is an NLR not involved in inflammasome assembly; instead, it is an essential transactivator required for both constitutive and inducible expression of class II HLA molecules.(25) We asked whether NLRP3 inflammasome activation and…”
BackgroundTuberculosis in the elderly: Why inflammation matters
Piergallini, T. J., & Turner, J. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.12.021 · Cited by 88
IFN-γ Regulation of the Type IV Class II Transactivator Promoter in Astrocytes
Dong, Y., Rohn, W. M., & Benveniste, E. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4731 · Cited by 101
Hodge, D. L., Martínez, A., Julias, J. G., Taylor, L. S., & Young, H. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.6.1742-1753.2002 · Cited by 76
“Since that time IFNhas been extensively studied and has been found to profoundly affect a variety of immune responses, which include upregulation of major histocompatibility complex class I and II expression (19, 49), proliferation and differentiation of lymphocyte populations (5, 54), and induction of genes that code…”
BackgroundRight place, right time, right peptide: DO keeps DM focused
Denzin, L. K., Fallas, J. L., Prendes, M., & Yi, W. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00302.x · Cited by 73
“Additionally, initial studies reported that DOB expression was not induced by IFN-g (94), whereas subsequent studies have shown otherwise (96, 97).”
BackgroundInfluentialMajumder, P., & Boss, J. M. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00327-10 · Cited by 73
“HLA-DOB, which is specifically expressed in B lymphocytes and is not responsive to IFN- induction in A-431 cells (42), also showed a 3C interaction following IFN- treatment.”
BackgroundInfluentialChen, M., Pockaj, B., Andreozzi, M., Barrett, M. T., Krishna, S., Eaton, S., Niu, R., & Anderson, K. S. (2018) · Clinical Breast Cancer · doi:10.1016/j.clbc.2018.05.006 · Cited by 71
Ma, K.-Y., Schonnesen, A. A., Brock, A., Berg, C. V. D., Eckhardt, S. G., Liu, Z., & Jiang, N. J. (2019) · JCI Insight · doi:10.1172/jci.insight.121387 · Cited by 79
Metadata
- Authors
- Steimle, V., Siegrist, C.-A., Mottet, A., Lisowska-Grospierre, B., & Mach, B.
- Affiliations
- University of Geneva (CH)
- Jeantet Laboratory of Molecular Genetics, Department of Genetics and Microbiology, University of Geneva Medical School, CH-1211 Geneva 4, Switzerland.
- INSERM U132, Hôpital des Enfants Malades, 15015 Paris, France.
- Venue
- Science
- Published
- 1994-07
- Volume
- 265
- Issue
- 5168
- Pages
- 106-109
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2060320549
- Cited by
- 898
- References
- 29
- Citations by year
- 2026: 33 · 2025: 35 · 2024: 39 · 2023: 49 · 2022: 35 · 2021: 32 · 2020: 25 · 2019: 20 · 2018: 22 · 2017: 19 · 2016: 27 · 2015: 21 · 2014: 18 · 2013: 13 · 2012: 29
- FWCI
- 13.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- MHC class II expression, interferon-gamma, CIITA, MHC class II deficiency, gene expression regulation, transcriptional activation
- MeSH terms
- Histocompatibility Antigens Class II, Cell Line, Chromosome Mapping, Chromosomes, Human, Pair 16, Fibroblasts, Gene Expression Regulation, Genes, MHC Class II, Humans, Interferon-gamma, Models, Genetic, Nuclear Proteins, RNA, Messenger, Transfection, Tumor Cells, Cultured, Trans-Activators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.